UBS Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.5M | Sell |
|
|||||
|
2025
Q2 | $11.8M | Sell |
|
|||||
|
2025
Q1 | $11.3M | Buy |
|
|||||
|
2024
Q4 | $5.79M | Buy |
|
|||||
|
2024
Q3 | $56.5K | Sell |
|
|||||
|
2024
Q2 | $281K | Sell |
|
|||||
|
2024
Q1 | $462K | Buy |
|
|||||
|
2023
Q4 | $14.3K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $86.3K | Sell |
|
|||||
|
2023
Q1 | $504K | Buy |
|
|||||
|
2022
Q4 | $448K | Sell |
|
|||||
|
2022
Q3 | $938K | Buy |
|
|||||
|
2022
Q2 | $440K | Sell |
|
|||||
|
2022
Q1 | $609K | Sell |
|
|||||
|
2021
Q4 | $1.13M | Buy |
|
|||||
|
2021
Q3 | $1.27M | Buy |
|
|||||
|
2021
Q2 | $902K | Buy |
|
|||||
|
2021
Q1 | $104K | Buy |
|
|||||
|
2020
Q4 | $0 | Buy |
|